Beraprost injection - United TherapeuticsAlternative Names: Beraprost Transcon; Transcon Beraprost
Latest Information Update: 16 Jun 2014
At a glance
- Originator Toray
- Developer Ascendis Pharma; United Therapeutics Corporation
- Class 3-ring heterocyclic compounds; Alkynes; Antiplatelets; Benzofurans; Butyric acids; Cyclopentanes; Prostaglandins; Small molecules; Vasodilators
- Mechanism of Action Prostacyclin agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Phase Unknown Pulmonary arterial hypertension
Most Recent Events
- 30 Sep 2012 Investigation in Pulmonary arterial hypertension in USA (SC)